Babies receive immunizations against RSV to prevent severe illness

Babies are now receiving immunizations against the dangerous Respiratory Syncytial Virus (RSV) for the first time. This aims to prevent severe illness and potential death in infants from RSV-induced respiratory infections. The immunization, called Nirsevimab, provides immediate protection for about six months. It contains pre-made antibodies, unlike a vaccine, and has minimal side effects. Globally, RSV is a leading cause of infant mortality. In the Netherlands, while deaths are rare, thousands of children are hospitalized annually, straining intensive care units.